Top Buy
Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▲ | Target price | Potential |
---|---|---|---|---|---|---|---|
Dr. Reddy's Laboratories Ltd. ADR | 6 | 1 | 1 | 0 | €63.00 | €74.65 | 18.485% |
MorphoSys AG | 7 | 0 | 0 | 0 | €69.45 | €65.00 | -6.407% |
Emergent Biosolutions Inc. | 2 | 3 | 0 | 0 | €5.11 | €4.65 | -8.953% |
Eledon Pharmaceuticals Inc. | 5 | 0 | 1 | 0 | €2.86 | €12.18 | 325.818% |
AstraZeneca plc | 2 | 0 | 1 | 0 | €141.65 | €165.00 | 16.484% |
Veracyte Inc. | 1 | 0 | 0 | 0 | €21.40 | - | - |
Bayer AG | 15 | 1 | 1 | 0 | €28.59 | €50.00 | 74.917% |
Knight Therapeutics | 1 | 0 | 0 | 0 | €4.08 | €10.00 | 145.098% |
VBI Vaccines Inc. | 1 | 0 | 0 | 0 | €0.59 | €3.00 | 408.475% |
Adverum Biotechnologies Inc. | 7 | 0 | 3 | 0 | €1.38 | €5.60 | 305.913% |
ProQR Therapeutics N.V. | 8 | 1 | 3 | 1 | €1.78 | €3.03 | 70.472% |
Uniqure B.V. | 1 | 0 | 1 | 0 | €4.61 | - | - |
Poxel S.A. | 1 | 0 | 0 | 0 | €0.58 | €0.70 | 21.739% |
Biolife Solutions Inc | 2 | 0 | 2 | 0 | €20.00 | €32.00 | 60.000% |
Axsome Therapeutics Inc | 2 | 0 | 0 | 0 | €70.44 | €100.00 | 41.965% |
Purple Biotech Ltd. ADR | 5 | 0 | 1 | 0 | €0.51 | €9.21 | 1705.294% |
Rhythm Pharmaceuticals | 15 | 0 | 2 | 0 | €35.00 | €45.98 | 31.371% |
Nektar Therapeutics | 3 | 1 | 0 | 0 | €1.62 | €3.70 | 129.102% |
Merck & Co. Inc. | 28 | 1 | 1 | 0 | €120.80 | €124.93 | 3.418% |
Catalyst Pharmaceutical Partners Inc | 11 | 0 | 1 | 0 | €15.18 | €24.13 | 58.980% |
Novo Nordisk A/S | 5 | 0 | 1 | 0 | €185.00 | €170.00 | -8.108% |
Trinity Biotech ADR | 22 | 0 | 0 | 0 | €0.41 | - | - |
Immutep LTD ADR | 1 | 0 | 0 | 0 | €2.60 | €4.00 | 53.846% |
Verastem Inc. | 10 | 0 | 1 | 0 | €10.60 | €24.63 | 132.404% |
Xeris Biopharma Holdings Inc. | 5 | 0 | 1 | 0 | €1.82 | €4.16 | 129.015% |